In summary, this is the first report to show that GEE efficiently delays AD progression via inducing a sustained stimulation of the IGF1R/CaMKIV/HAT/BDNF pathway, which not only provides a promising strategy for early intervention of AD but also reveals novel molecular mechanisms for the lasting enhanced brain plasticity induced by GEE. This evidence concerns the gene IGF1R and Alzheimer disease.